Impact of dimethyl fumarate (DMF) treatment on immune tolerance during multiple sclerosis

被引：0
|
作者：
Maniscalco, G. T. [1 ]
机构：
[1] Cardarelli Hosp, Neurol Clin, Naples, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1619
引用
收藏
页码：848 / 849
页数：2
相关论文
共 50 条
  • [41] MULTIPLE SCLEROSIS Dimethyl fumarate is coming of age
    Tintore, Mar
    Sastre-Garriga, Jaume
    NATURE REVIEWS NEUROLOGY, 2016, 12 (08) : 436 - 437
  • [42] Longitudinal and Cross Sectional Study of Adipocytokine and Vitamin D in Multiple Sclerosis Patients Treated with Dimethyl Fumarate (DMF)
    Baharnoori, Moogeh
    Gonzalez, Cindy T.
    Saxena, Shrishti
    Keyhanian, Kiandokht
    Kivisakk, Pia
    Healy, Brian C.
    Weiner, Howard
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 30 - 30
  • [43] Longitudinal and Cross Sectional Study of Adipocytokine and Vitamin D in Multiple Sclerosis Patients Treated with Dimethyl Fumarate (DMF)
    Baharnoori, Moogeh
    Gonzalez, Cindy T.
    Saxena, Shrishti
    Keyhanian, Kiandokht
    Kivisakk, Pia
    Healy, Brian
    Weiner, Howard
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [44] Dimethyl-fumarate for multiple sclerosis in real life: impact on cortical pathology
    Zuco, C.
    Marastoni, D.
    Pitteri, M.
    Pisani, A.
    Crescenzo, F.
    Castellaro, M.
    Pizzini, F.
    Guandalini, M.
    Ziccardi, S.
    Scalfari, A.
    Magliozzi, R.
    Calabrese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 746 - 746
  • [45] Lymphopenia during treatment with dimethyl fumarate in patients with multiple sclerosis: Prevalence, predicting factors and clinical outcomes
    Dinoto, Alessandro
    Sartori, Arianna
    Cheli, Marta
    Pasquin, Fulvio
    Baldini, Sara
    Bratina, Alessio
    Bosco, Antonio
    Manganotti, Paolo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [46] Dimethyl fumarate versus interferon for treatment of relapsing-remitting multiple Sclerosis
    Sattarnezhad, Neda
    Healy, Brian C.
    Baharnoori, Moogeh
    Diaz-Cruz, Camilo
    Stankiewicz, James
    Weiner, Howard L.
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [47] Comparison of Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two Year Experience
    Vollmer, Brandi
    Nair, Kavita
    Sillau, Stefan
    Corboy, John
    Vollmer, Timothy
    Alvarez, Enrique
    NEUROLOGY, 2016, 86
  • [48] Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients
    Baharnoori, Moogeh
    Wilson, Ryan
    Saxena, Shrishti
    Gonzalez, Cindy T.
    Sotiropoulos, Marinos G.
    Keyhanian, Kiandokht
    Healy, Brian C.
    Chitnis, Tanuja
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 56
  • [49] COST EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE VERSUS TERIFLUNOMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Ruiz, L.
    Machado, L.
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Harrington, A.
    VALUE IN HEALTH, 2017, 20 (09) : A724 - A724
  • [50] Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side Effects
    Linker, Ralf A.
    Gold, Ralf
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2013, 13 (11)
12345